| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sanae Kanno, Seishiro Hirano, Fujio Kayam. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts. Toxicology. vol 203. issue 1-3. 2004-11-19. PMID:15363596. |
rt-pcr analyses revealed that coumestrol (10 microm) decreased mrna levels of calcitonin receptor (ctr) and matrix metalloproteinase-9 (mmp9) in rankl-treated cells. |
2004-11-19 |
2023-08-12 |
Not clear |
| Yoon Kyung Jeon, Bo Young Lee, Ji Eun Kim, Seung Sook Lee, Chul Woo Ki. Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea. Head & neck. vol 26. issue 7. 2004-10-12. PMID:15229899. |
we evaluated the characteristics of nasopharyngeal carcinoma in korea, including its clinical, pathologic, and molecular features, especially emphasizing on the ebv strains involved, latent membrane protein 1 (lmp1) expression, and the alterations of matrix metalloproteinase 9 (mmp9) and e-cadherin expression. |
2004-10-12 |
2023-08-12 |
Not clear |
| Amal M Mangoud, Samia M Sanad, Ahmed Hendawy, Gaber el-Hady, Gehad T el-Sherbin. Non-histological assessment of liver fibrosis in HCV infection. Journal of the Egyptian Society of Parasitology. vol 34. issue 2. 2004-09-28. PMID:15287165. |
this study found a correlation between some serum markers [ast/alt ratio, level of matrix metalloproteinase 9 (mmp9), level of viraemia and hcv serotype] and severity of liver fibrosis in hcv-infected patients. |
2004-09-28 |
2023-08-12 |
human |
| Lynda Ferrigan, William A H Wallac. Predicting non-small cell lung cancer expression of epidermal growth factor receptor and matrix metalloproteinase 9 from immunohistochemical staining of diagnostic biopsy samples. European journal of cancer (Oxford, England : 1990). vol 40. issue 10. 2004-08-24. PMID:15196544. |
epidermal growth factor receptor (egfr) and matrix metalloproteinase 9 (mmp9) expression in resected non-small cell lung cancer (nsclc) has been associated with a poor prognosis. |
2004-08-24 |
2023-08-12 |
Not clear |
| Xue-pei Zhang, Peng-fei Shen, Cheng Zho. [Diagnosis and follow-up value of quantitative examination of MMP9 in the urine of BTCC patients]. Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University. vol 28. issue 1. 2004-07-22. PMID:12934404. |
to explore the value of quantitative examination of total matrix metalloproteinase-9 (mmp9) in the urine of bladder transitional cell carcinoma (btcc) patients. |
2004-07-22 |
2023-08-12 |
Not clear |
| Jacky Arkell, Christopher J Jackso. Constitutive secretion of MMP9 by early-passage cultured human endothelial cells. Cell biochemistry and function. vol 21. issue 4. 2004-07-07. PMID:14624478. |
matrix metalloproteinase-9 (mmp9) plays an important role during angiogenesis. |
2004-07-07 |
2023-08-12 |
human |
| Evan P Adler, Charles A Lemken, Nicholas S Katchen, Robert A Kur. A dual role for tumor-derived chemokine RANTES (CCL5). Immunology letters. vol 90. issue 2-3. 2004-04-02. PMID:14687724. |
these data are consistent with the ability of ccl5 to upregulate transcription of matrix metalloproteinase-9 (mmp9), which can contribute to angiogenesis and thus, foster growth in vivo. |
2004-04-02 |
2023-08-12 |
mouse |
| Shohei Hirakawa, Ethan M Lange, Carla J Colicigno, Barry I Freedman, Stephen S Rich, Donald W Bowde. Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients. American journal of kidney diseases : the official journal of the National Kidney Foundation. vol 42. issue 1. 2004-03-25. PMID:12830465. |
evaluation of genetic variation and association in the matrix metalloproteinase 9 (mmp9) gene in esrd patients. |
2004-03-25 |
2023-08-12 |
Not clear |
| Shohei Hirakawa, Ethan M Lange, Carla J Colicigno, Barry I Freedman, Stephen S Rich, Donald W Bowde. Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients. American journal of kidney diseases : the official journal of the National Kidney Foundation. vol 42. issue 1. 2004-03-25. PMID:12830465. |
expression of the matrix metalloproteinase 9 (mmp9) gene is increased in a variety of renal diseases. |
2004-03-25 |
2023-08-12 |
Not clear |
| F Gaultier, A Foucault-Bertaud, E Lamy, A L Ejeil, S M Dridi, N Piccardi, A Piccirilli, P Msika, G Godeau, B Gogl. Effects of a vegetable extract from Lupinus albus (LU105) on the production of matrix metalloproteinases (MMP1, MMP2, MMP9) and tissue inhibitor of metalloproteinases (TIMP1, TIMP2) by human gingival fibroblasts in culture. Clinical oral investigations. vol 7. issue 4. 2004-02-18. PMID:12802622. |
effects of a vegetable extract from lupinus albus (lu105) on the production of matrix metalloproteinases (mmp1, mmp2, mmp9) and tissue inhibitor of metalloproteinases (timp1, timp2) by human gingival fibroblasts in culture. |
2004-02-18 |
2023-08-12 |
human |
| Junichiro Kamochi, Tetsuji Tokunaga, Yasushi Tomii, Yoshiyuki Abe, Hiroyuki Hatanaka, Hiroshi Kijima, Hitoshi Yamazaki, Norihito Watanabe, Shohei Matsuzaki, Yoshito Ueyama, Masato Nakamur. Overexpression of the thrombospondin 2 (TSP2) gene modulated by the matrix metalloproteinase family expression and production in human colon carcinoma cell line. Oncology reports. vol 10. issue 4. 2004-02-06. PMID:12792739. |
the transformants with the human tsp2 gene overexpression showed a down-regulation of matrix metalloproteinase 2 (mmp2) and mmp9 in comparison to those with vector-control. |
2004-02-06 |
2023-08-12 |
human |
| Sylvia Fong, Leslie Mounkes, Yong Liu, Michael Maibaum, Eric Alonzo, Pierre-Yves Desprez, Ann D Thor, Mohammed Kashani-Sabet, Robert J Deb. Functional identification of distinct sets of antitumor activities mediated by the FKBP gene family. Proceedings of the National Academy of Sciences of the United States of America. vol 100. issue 24. 2004-02-02. PMID:14612567. |
we then used gene expression profiling to identify syndecan 1 (sdc1) and matrix metalloproteinase 9 (mmp9) as genes directly regulated by fkbp1a and fkbp8. |
2004-02-02 |
2023-08-12 |
mouse |
| Koh-ichi Sakata, Masaaki Satoh, Masanori Someya, Hiroko Asanuma, Hisayasu Nagakura, Atushi Oouchi, Kensei Nakata, Katsuhisa Kogawa, Kazumitsu Koito, Masato Hareyama, Tetsuo Him. Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma. Cancer. vol 100. issue 2. 2004-01-30. PMID:14716772. |
in in vitro studies, matrix metalloproteinase 9 (mmp9) was reportedly expressed by human nhl cells and elevated levels of mmp9 have been observed in a subset of patients with high-grade nhl. |
2004-01-30 |
2023-08-12 |
human |
| Hirotaka Kuga, Takashi Morisaki, Katsuya Nakamura, Hideya Onishi, Hirokazu Noshiro, Akihiko Uchiyama, Masao Tanaka, Mitsuo Katan. Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model. Oncogene. vol 22. issue 49. 2003-12-03. PMID:14586410. |
tgf-beta induced the enhanced expression of matrix metalloproteinase 9 (mmp9) and urokinase-type plasminogen activator (upa) in gctm-1 at both the protein and enzymatic activity levels. |
2003-12-03 |
2023-08-12 |
human |
| Dorina Belotti, Paola Paganoni, Luigi Manenti, Angela Garofalo, Sergio Marchini, Giulia Taraboletti, Raffaella Giavazz. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer research. vol 63. issue 17. 2003-11-06. PMID:14500349. |
matrix metalloproteinases (mmp9 and mmp2) induce the release of vascular endothelial growth factor (vegf) by ovarian carcinoma cells: implications for ascites formation. |
2003-11-06 |
2023-08-12 |
mouse |
| Céline Colnot, Zachary Thompson, Theodore Miclau, Zena Werb, Jill A Helm. Altered fracture repair in the absence of MMP9. Development (Cambridge, England). vol 130. issue 17. 2003-10-06. PMID:12874132. |
here, we provide the first genetic evidence that matrix metalloproteinase 9 (mmp9) regulates crucial events during adult fracture repair. |
2003-10-06 |
2023-08-12 |
mouse |
| Yi Sun, Lu-Jia Don. [Role of matrix metalloproteinases in the pathogenesis and therapy of leukemia]. Zhongguo shi yan xue ye xue za zhi. vol 11. issue 3. 2003-09-09. PMID:12844422. |
mmp2 and mmp9 are the unique types of proteinase that hydrolyze the bone structure of excellulary matrix (type iv collagen). |
2003-09-09 |
2023-08-12 |
Not clear |
| J E Nutt, G C Durkan, J K Mellon, J Lune. Matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urine. BJU international. vol 91. issue 1. 2003-03-25. PMID:12614260. |
matrix metalloproteinases (mmps) in bladder cancer: the induction of mmp9 by epidermal growth factor and its detection in urine. |
2003-03-25 |
2023-08-12 |
Not clear |
| Brigitte Lelongt, Pierre Ronc. Role of matrix metalloproteinases in kidney development and glomerulopathy: lessons from transgenic mice. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. vol 17 Suppl 9. 2003-03-18. PMID:12386280. |
matrix metalloproteinase-9 (mmp9) is required for renal organogenesis in vitro and is increased in various nephropathies. |
2003-03-18 |
2023-08-12 |
mouse |
| Alison M Wallace, Andrew J Sandfor. Genetic polymorphisms of matrix metalloproteinases: functional importance in the development of chronic obstructive pulmonary disease? American journal of pharmacogenomics : genomics-related research in drug development and clinical practice. vol 2. issue 3. 2003-03-03. PMID:12383023. |
here we review evidence that genetic polymorphisms in matrix metalloproteinase genes mmp1, mmp9 and mmp12 may be important in the development of copd. |
2003-03-03 |
2023-08-12 |
Not clear |